Article Versions Notes

Lee P-H, Huang Y-H, Hsu Y-W, Chen K-C, Hsu K-H, Lin H, Lee T-Y, Tseng J-S, Chang G-C, Yang T-Y. Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment. Journal of Clinical Medicine. 2023; 12(1):231. https://doi.org/10.3390/jcm12010231

Lee, Po-Hsin, Yen-Hsiang Huang, Yu-Wei Hsu, Kun-Chieh Chen, Kuo-Hsuan Hsu, Ho Lin, Teng-Yu Lee, Jeng-Sen Tseng, Gee-Chen Chang, and Tsung-Ying Yang. 2023. "Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment" Journal of Clinical Medicine 12, no. 1: 231. https://doi.org/10.3390/jcm12010231

Lee, P.-H., Huang, Y.-H., Hsu, Y.-W., Chen, K.-C., Hsu, K.-H., Lin, H., Lee, T.-Y., Tseng, J.-S., Chang, G.-C., & Yang, T.-Y. (2023). Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment. Journal of Clinical Medicine, 12(1), 231. https://doi.org/10.3390/jcm12010231